As of January 22, 2025, Orion Corporation (ORNAV.HE) has a market cap of $7.26 billion USD. According to our data, Orion Corporation is ranked No.2107 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $7.26 B |
399.63%
|
Dec 29, 2024 | $1.45 B |
13.16%
|
Dec 28, 2023 | $1.28 B |
-20.33%
|
Dec 29, 2022 | $1.61 B |
46.77%
|
Dec 29, 2021 | $1.10 B |
0.51%
|
Dec 29, 2020 | $1.09 B |
-5.73%
|
Dec 29, 2019 | $1.16 B |
41.33%
|
Dec 27, 2018 | $0.82 B |
-0.82%
|
Dec 28, 2017 | $0.83 B |
-22.29%
|
Dec 29, 2016 | $1.06 B |
39.15%
|
Dec 29, 2015 | $0.77 B |
33.12%
|
Dec 29, 2014 | $0.57 B |
30.03%
|
Dec 29, 2013 | $0.44 B |
-1.94%
|
Dec 30, 2012 | $0.45 B |
46.30%
|
Dec 29, 2011 | $0.31 B |
-0.44%
|
Dec 30, 2010 | $0.31 B |
9.52%
|
Dec 29, 2009 | $0.28 B |
35.73%
|
Dec 29, 2008 | $0.21 B |
-20.12%
|
Dec 27, 2007 | $0.26 B |
3.83%
|
Dec 28, 2006 | $0.25 B |
5.26%
|
Dec 29, 2005 | $0.24 B |
29.46%
|
Dec 30, 2004 | $0.18 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Pfizer
PFE
|
$148.34 B |
-0.006 M
|
USA
|
GlaxoSmithKline
GSK
|
$68.43 B |
-0.001 M
|
UK
|
Merck
MRK
|
$242.59 B |
0.007 M
|
USA
|
Johnson & Johnson
JNJ
|
$347.78 B |
-0.005 M
|
USA
|
Novartis
NVS
|
$197.43 B |
0.007 M
|
Switzerland
|
AstraZeneca
AZN
|
$211.43 B |
0.005 M
|
UK
|
Sanofi
SNY
|
$128.55 B |
0.003 M
|
France
|
AbbVie
ABBV
|
$300.53 B |
0.002 M
|
USA
|
Bristol-Myers Squibb
BMY
|
$115.86 B |
0.003 M
|
USA
|
Eli Lilly
LLY
|
$676.92 B |
0.020 M
|
USA
|
Amgen
AMGN
|
$147.53 B |
0.002 M
|
USA
|
Teva Pharmaceutical Industries
TEVA
|
$24.69 B |
-0.037 B
|
Israel
|
Takeda Pharmaceutical
TAK
|
$41.29 B |
-0.238 B
|
Japan
|
Market Cap | = | ORNAV.HE Stock Price | * | ORNAV.HE Shares Outstanding |
= | $51.27 | * | 32.75 M | |
= | $7.26 B |